Your browser doesn't support javascript.
loading
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option.
Ferraro, Sara; Convertino, Irma; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Tuccori, Marco.
Affiliation
  • Ferraro S; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italy.
  • Convertino I; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italy.
  • Cappello E; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italy.
  • Valdiserra G; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italy.
  • Bonaso M; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italy.
  • Tuccori M; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italy.
Expert Opin Drug Discov ; 19(1): 9-20, 2024.
Article in En | MEDLINE | ID: mdl-37830361
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Expert Opin Drug Discov Year: 2024 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Expert Opin Drug Discov Year: 2024 Document type: Article Country of publication: United kingdom